Mimedx (MDXG) Non-Current Deferred Tax Liability (2016)

Mimedx's (MDXG) quarterly Non-Current Deferred Tax Liability came in at $1.1 million in Q4 2016.

Analysis

Mimedx (MDXG) Non-Current Deferred Tax Liability (2016) Analysis & Trends

Mimedx has disclosed Non-Current Deferred Tax Liability across 1 years of filings, most recently posting $1.1 million for Q4 2016.

In Q4 2016, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2016 stood at $1.1 million (changed N/A YoY), while the FY2016 annual figure was $1.1 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability came in at $1.1 million for Q4 2016 at Mimedx.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 million in Q4 2016 to a low of $1.1 million in Q4 2016.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	181.19 Bn	175.58 Bn	7.27 Bn
2	Intuitive Surgical	127.77 Bn	122.55 Bn	1.96 Bn
3	Medtronic	117.13 Bn	108.31 Bn	6.34 Bn
4	Stryker	104.67 Bn	101.20 Bn	4.50 Bn
5	Boston Scientific	64.48 Bn	63.94 Bn	3.85 Bn
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn
7	Alcon	33.06 Bn	31.61 Bn	1.68 Bn
8	Dexcom	32.37 Bn	30.43 Bn	830.00 Mn
9	Steris	20.76 Bn	20.28 Bn	684.20 Mn
10	Mimedx	667.30 Mn	531.46 Mn	44.38 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2016	1.13 Mn